Published in Am J Gastroenterol on June 19, 2012
Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol (2013) 4.10
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome (2014) 1.82
Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2015) 1.47
Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea? Am J Gastroenterol (2013) 1.32
Proton pump inhibitors alter the composition of the gut microbiota. Gut (2015) 1.28
Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist (2014) 1.21
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. PLoS Med (2014) 1.20
Proton pump inhibitors affect the gut microbiome. Gut (2015) 1.17
Epidemiology of Clostridium difficile infection. J Pharm Pract (2013) 1.10
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08
Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation. Am J Gastroenterol (2013) 1.00
Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients. J Gen Intern Med (2015) 0.98
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
How much do PPIs contribute to C. difficile infections? Am J Gastroenterol (2012) 0.91
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug Healthc Patient Saf (2015) 0.89
Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Clin Infect Dis (2015) 0.89
Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care (2014) 0.87
Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (2013) 0.87
Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol (2014) 0.85
Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich. BMC Infect Dis (2014) 0.84
Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int (2013) 0.83
Risk factors associated with Clostridium difficile infection in adult oncology patients. Support Care Cancer (2014) 0.83
The simple predictors of pseudomembranous colitis in patients with hospital-acquired diarrhea: a prospective observational study. Gut Liver (2013) 0.81
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. World J Crit Care Med (2016) 0.80
Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One (2015) 0.79
Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review. World J Gastroenterol (2014) 0.79
Acid suppression and the risk of Clostridium difficile infection. J Pediatr (2013) 0.79
Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy. Springerplus (2016) 0.79
Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol (2014) 0.79
Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit. Am J Gastroenterol (2016) 0.79
Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile. Open Forum Infect Dis (2014) 0.78
Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis. Clin Gastroenterol Hepatol (2016) 0.78
Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterol J (2015) 0.78
Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis (2015) 0.77
Clostridium difficile infection in the community: are proton pump inhibitors to blame? World J Gastroenterol (2013) 0.77
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback. BMC Infect Dis (2016) 0.77
Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep (2015) 0.77
Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis. Sci Rep (2016) 0.76
Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure. Hepat Mon (2014) 0.76
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole. Clin Interv Aging (2013) 0.76
Clostridium difficile: an emerging pathogen in children. Discov Med (2012) 0.75
Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugs. CMAJ (2015) 0.75
Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection. Gut Liver (2016) 0.75
Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radic Biol Med (2016) 0.75
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs (2017) 0.75
Halitosis and helicobacter pylori infection: A meta-analysis. Medicine (Baltimore) (2016) 0.75
Response to Freedberg and Abrams. Am J Gastroenterol (2013) 0.75
Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease. Sci Rep (2016) 0.75
National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals. BMC Infect Dis (2016) 0.75
Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs. J Vet Intern Med (2016) 0.75
Acid suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol (2017) 0.75
Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2017) 0.75
Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem? Gastroenterology Res (2013) 0.75
Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority. Int J Environ Res Public Health (2017) 0.75
Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward Clostridium difficile Toxins TcdA and TcdB. Front Cell Infect Microbiol (2017) 0.75
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. BMC Infect Dis (2016) 0.75
Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus. Dig Dis Sci (2014) 0.75
Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective. Curr Gastroenterol Rep (2017) 0.75
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. JAMA Intern Med (2017) 0.75
Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist? Gut Liver (2017) 0.75
Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study. Support Care Cancer (2017) 0.75
Association between omeprazole use and Clostridium difficile infection among hospitalized patients: A case-control study of the Saudi population. Qatar Med J (2017) 0.75
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12
ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc (2004) 2.33
Celiac plexus neurolysis for pain relief in pancreatic cancer. J Support Oncol (2009) 2.32
ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc (2005) 2.11
Esophageal stenting for the palliation of malignant dysphagia. J Support Oncol (2008) 2.08
Endoscopic therapy for malignant bowel obstruction. J Support Oncol (2007) 2.07
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc (2005) 1.99
A retrospective study of nurse-assisted propofol sedation in patients with amyotrophic lateral sclerosis undergoing percutaneous endoscopic gastrostomy. Nutr Clin Pract (2012) 1.98
Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc (2008) 1.95
Overtube use in gastrointestinal endoscopy. Gastrointest Endosc (2009) 1.94
Chromoendoscopy. Gastrointest Endosc (2007) 1.74
ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc (2005) 1.74
Esophageal dilation. Gastrointest Endosc (2006) 1.68
Narrow band imaging and multiband imaging. Gastrointest Endosc (2008) 1.65
Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology (2014) 1.58
Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients. Dig Dis Sci (2012) 1.55
EUS training and practice patterns among gastroenterologists completing training since 1993. Gastrointest Endosc (2005) 1.51
Rapid on-site evaluation reduces needle passes in endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions: a risk-benefit analysis. Dig Dis Sci (2013) 1.46
Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and UroVysion™ fluorescent in situ hybridization. Diagn Cytopathol (2011) 1.40
Small-intestinal B-cell lymphoma manifesting as pneumobilia secondary to involvement of the major duodenal papilla. Gastrointest Endosc (2006) 1.39
Fast-food bolus nation. Gastrointest Endosc (2006) 1.39
ASGE Guideline: the role of endoscopy in the patient with lower-GI bleeding. Gastrointest Endosc (2005) 1.39
Clinical Outcomes, Efficacy, and Adverse Events in Patients Undergoing Esophageal Stent Placement for Benign Indications: A Large Multicenter Study. J Clin Gastroenterol (2016) 1.38
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc (2006) 1.36
EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc (2006) 1.35
Large colonic lipomas. Gastroenterol Hepatol (N Y) (2011) 1.33
A comparative needle study: EUS-FNA procedures using the HD ProCore(™) and EchoTip(®) 22-gauge needle types. Diagn Cytopathol (2013) 1.32
ASGE guideline: complications of EUS. Gastrointest Endosc (2005) 1.32
Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes. Gastrointest Endosc (2007) 1.31
Can U.S. GI fellowship programs meet American Society for Gastrointestinal Endoscopy recommendations for training in EUS? A survey of U.S. GI fellowship program directors. Gastrointest Endosc (2006) 1.29
The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc (2006) 1.28
The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc (2006) 1.26
Large colonic lipoma mimicking colon cancer and causing colonic intussusception. Dig Dis Sci (2008) 1.25
Principles of training in GI endoscopy. Gastrointest Endosc (2011) 1.25
ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc (2005) 1.23
Role of EUS. Gastrointest Endosc (2007) 1.23
Needle size has only a limited effect on outcomes in EUS-guided fine needle aspiration: a systematic review and meta-analysis. Dig Dis Sci (2012) 1.23
Colonoscopy core curriculum. Gastrointest Endosc (2012) 1.20
Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol (2013) 1.20
Screening for pancreatic cancer: why, how, and who? Ann Surg (2013) 1.19
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Capsule endoscopy of the colon. Gastrointest Endosc (2008) 1.16
ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc (2005) 1.13
Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc (2012) 1.13
Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci (2012) 1.12
Osteoclastic and pleomorphic giant cell tumors of the pancreas diagnosed via EUS-guided FNA: unique clinical, endoscopic, and pathologic findings in a series of 5 patients. Gastrointest Endosc (2009) 1.08
EUS in pediatric patients. Gastrointest Endosc (2009) 1.07
Metastatic disease to the pancreas documented by endoscopic ultrasound guided fine-needle aspiration: a seven-year experience. Diagn Cytopathol (2010) 1.07
Endoscopic hemostatic devices. Gastrointest Endosc (2009) 1.05
Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective. Dig Dis Sci (2011) 1.05
ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc (2006) 1.03
Colonoscopy preparation. Gastrointest Endosc (2009) 1.01
Role of endoscopy in the management of GERD. Gastrointest Endosc (2007) 1.00
Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc (2010) 1.00
Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study. Dig Dis Sci (2012) 1.00
Informed consent for GI endoscopy. Gastrointest Endosc (2007) 0.99
Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas (2013) 0.98
Complications of temporary pancreatic stent insertion for pancreaticojejunal anastomosis during pancreaticoduodenectomy. Gastrointest Endosc (2004) 0.97
Biliary and pancreatic stone extraction devices. Gastrointest Endosc (2009) 0.96
Primary sclerosing cholangitis and distribution of inflammatory bowel disease. Clin Gastroenterol Hepatol (2012) 0.95
Endoscopic retrieval devices. Gastrointest Endosc (2009) 0.95
Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw (2010) 0.94
High-resolution and high-magnification endoscopes. Gastrointest Endosc (2009) 0.94
Confocal laser endomicroscopy. Gastrointest Endosc (2009) 0.94
Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci (2010) 0.94
Effect of the time of day and queue position in the endoscopic schedule on the performance characteristics of endoscopic ultrasound-guided fine-needle aspiration for diagnosing pancreatic malignancies. Endosc Ultrasound (2016) 0.93
Endocytoscopy. Gastrointest Endosc (2009) 0.93
ASGE guideline: guidelines for credentialing and granting privileges for capsule endoscopy. Gastrointest Endosc (2005) 0.93
Interventional EUS. Gastrointest Endosc (2010) 0.92
Echoendoscopes. Gastrointest Endosc (2007) 0.92
Short-wire ERCP systems. Gastrointest Endosc (2007) 0.92
Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am (2011) 0.92
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2009) 0.92
Quality indicators for ERCP. Gastrointest Endosc (2014) 0.92
Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features. World J Gastrointest Endosc (2010) 0.91
Post-ERCP pancreatitis: review of current preventive strategies. Curr Opin Gastroenterol (2012) 0.90
Quality indicators for EUS. Gastrointest Endosc (2014) 0.90
ERCP cannulation and sphincterotomy devices. Gastrointest Endosc (2010) 0.89
EUS accessories. Gastrointest Endosc (2007) 0.88
Impact of rapid on-site evaluation on the adequacy of endoscopic-ultrasound guided fine-needle aspiration of solid pancreatic lesions: a systematic review and meta-analysis. J Gastroenterol Hepatol (2014) 0.88
Quality indicators for EGD. Am J Gastroenterol (2014) 0.87
Pneumatosis coli in the setting of severe ulcerative colitis: a case report. Dig Dis Sci (2006) 0.86
Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc (2007) 0.86
Natural orifice translumenal endoscopic surgery. Gastrointest Endosc (2008) 0.86
Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol (2007) 0.85
Post-ERCP pancreatitis and its prevention. Nat Clin Pract Gastroenterol Hepatol (2006) 0.85
Enteroscopes. Gastrointest Endosc (2007) 0.85
Demographics of a large cohort of urban chronic hepatitis C patients. Hepatol Int (2008) 0.85
ASGE guideline: guideline on the use of endoscopy in the management of constipation. Gastrointest Endosc (2005) 0.84
Quality indicators common to all GI endoscopic procedures. Am J Gastroenterol (2014) 0.84
EUS core curriculum. Gastrointest Endosc (2012) 0.84
Zinc toxicity from massive and prolonged coin ingestion in an adult. Am J Med Sci (2008) 0.83
Small-bowel endoscopy core curriculum. Gastrointest Endosc (2013) 0.82
Endoscopic electronic medical record systems. Gastrointest Endosc (2008) 0.82